CUTANEOUS MELANOMA: A FOCUS ON OUR PATIENTS
In July of 2021, 31-year-old Morgan England noticed a spot on her arm that didn’t look like it used to. Following her next routine dermatology appointment her world began to change. Morgan’s story underscores the importance of being an advocate for your own health.
Separately, a recent study - conducted in collaboration with the Melanoma Research Foundation - confirmed that the vast majority of patients with melanoma desire prognostic testing - in fact, 9 out of 10!
NEWS & UPDATES
The Skin Cancer Foundation Partners with Castle Biosciences to Educate Patients on Emerging Technologies for High-Risk Skin Cancers
The Skin Cancer Foundation, one of the leading sources of education for patients looking for information about skin cancer, partnered with Castle to educate patients on emerging technologies for high-risk skin cancers. The article breaks down the facts about genomic testing for both invasive melanomas and high-risk squamous cell carcinomas.
RESEARCH & DEVELOPMENT
Hot Off the (Digital) Press! New DecisionDx-SCC Clinical Utility Publication in Cancer Investigation
Read the latest DecisionDx-SCC clinical utility study, Hooper et al. Cancer Investigation 2022, highlighting how real-world evidence substantiates that the test is appropriately utilized by clinicians and that the personalized risk-stratification results are impactful in guiding risk-aligned patient management in SCC.
CASE STUDY OF THE MONTH
Irregular Papule with Atypical Histopathological Findings and Borderline/ Unknown Diagnosis
A 43-year-old female patient presents to a dermatologist with a suspicious irregular multi-colored papule on the right dorsal foot.